BeOne Medicines Ltd.
ONC
41 insider filings · Latest: Jun 23, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Jun 15, 2026 | Jun 15 8:21 PM | CORAZON D. SANDERS | Proposed Sale | 945 | $265.50 | $250.9K | — | View → |
| Jun 11, 2026 | Jun 11 8:32 PM | XIAOBIN WU | Proposed Sale | 626 | $261.20 | $163.5K | — | View → |
| Jun 11, 2026 | Jun 11 8:29 PM | LAI WANG | Proposed Sale | 756 | $261.42 | $197.6K | — | View → |
| Jun 11, 2026 | Jun 11 8:25 PM | AARON ROSENBERG | Proposed Sale | 631 | $257.74 | $162.6K | — | View → |
| Jun 11, 2026 | Jun 11 8:24 PM | TITUS BENJAMIN BALL | Proposed Sale | 169 | $257.20 | $43.5K | — | View → |
| Jun 11, 2026 | Jun 11 8:23 PM | CHAN LEE | Proposed Sale | 428 | $257.64 | $110.3K | — | View → |
| Jun 11, 2026 | Jun 11 8:23 PM | JOHN OYLER | Proposed Sale | 1,949 | $257.24 | $501.4K | — | View → |
| Jun 8, 2026 | Jun 10 9:27 PM | Titus B. BallPrincipal Accounting Officer | Sale | 136 | $271.33 | $36.9K | 0(D) | View → |
| Jun 8, 2026 | Jun 10 9:26 PM | Chan Henry LeeSVP, General Counsel | Sale | 871 | $270.42 | $235.5K | 0(D) | View → |
| Jun 8, 2026 | Jun 10 9:25 PM | Lai WangPresident, Global Head of R&D | Sale | 1,367 | $269.38 | $368.2K | 0(D) | View → |
| Jun 8, 2026 | Jun 10 9:23 PM | Xiaobin WuPresident and COO | Sale | 1,484 | $269.37 | $399.7K | 0(D) | View → |
| Jun 8, 2026 | Jun 10 9:22 PM | John OylerDirector, Chief Executive Officer | Sale | 4,940 | $270.56 | $1.3M | 0(D) | View → |
| Jun 8, 2026 | Jun 8 8:31 PM | TITUS BENJAMIN BALL | Proposed Sale | 136 | $271.33 | $36.9K | — | View → |
| Jun 8, 2026 | Jun 8 8:29 PM | CHAN LEE | Proposed Sale | 871 | $270.42 | $235.5K | — | View → |
| Jun 8, 2026 | Jun 8 8:28 PM | LAI WANG | Proposed Sale | 1,367 | $269.38 | $368.2K | — | View → |
| Jun 8, 2026 | Jun 8 8:23 PM | XIAOBIN WU | Proposed Sale | 1,484 | $269.37 | $399.7K | — | View → |
| Jun 8, 2026 | Jun 8 8:18 PM | JOHN OYLER | Proposed Sale | 4,940 | $270.56 | $1.3M | — | View → |
| Jun 1, 2026 | Jun 3 8:10 PM | Qingqing YiDirector | Sale | 235 | $279.13 | $65.6K | 0(D) | View → |
| Jun 1, 2026 | Jun 1 8:27 PM | QINGQING YI | Proposed Sale | 235 | $279.13 | $65.6K | — | View → |
| May 22, 2026 | May 27 9:29 PM | Alessandro RivaDirector | Sale | 212 | $309.51 | $65.6K | 0(D) | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Jun 11, 2026 | Jun 15 9:55 PM | Lai WangPresident, Global Head of R&D | Grant/Award | 229,775 | — | 229,775(D) | View → |
| Jun 11, 2026 | Jun 15 9:55 PM | Aaron RosenbergChief Financial Officer | Grant/Award | 137,865 | — | 137,865(D) | View → |
| Jun 11, 2026 | Jun 15 9:55 PM | Xiaobin WuPresident and COO | Grant/Award | 229,775 | — | 229,775(D) | View → |
| Jun 11, 2026 | Jun 15 9:55 PM | Chan Henry LeeSVP, General Counsel | Grant/Award | 87,308 | — | 87,308(D) | View → |
| Jun 11, 2026 | Jun 15 9:55 PM | John OylerDirector, Chief Executive Officer | Grant/Award | 344,669 | — | 344,669(D) | View → |
| Jun 11, 2026 | Jun 15 9:54 PM | Xiaodong WangDirector, Other | Grant/Award | 193,492 | — | 193,492(D) | View → |
| May 13, 2026 | May 15 8:39 PM | Chan Henry LeeSVP, General Counsel | Option Exercise | 4,316 | — | 107,848(D) | View → |
| Apr 8, 2026 | Apr 10 9:40 PM | Chan Henry LeeSVP, General Counsel | Option Exercise | 4,316 | — | 109,122(D) | View → |
| Mar 11, 2026 | Mar 13 9:26 PM | Chan Henry LeeSVP, General Counsel | Option Exercise | 4,433 | — | 110,396(D) | View → |
| Feb 4, 2026 | Feb 6 9:57 PM | Chan Henry LeeSVP, General Counsel | Option Exercise | 21,580 | — | 111,670(D) | View → |